Actionable Gene Expression-Based Patient Stratification for Molecular Targeted Therapy in Hepatocellular Carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Actionable Gene Expression-Based Patient Stratification for Molecular Targeted Therapy in Hepatocellular Carcinoma
Authors
Keywords
Gene expression, Hepatocellular carcinoma, Cancer treatment, Hyperexpression techniques, Biomarkers, Clustering algorithms, Reverse transcriptase-polymerase chain reaction, Cluster trials
Journal
PLoS One
Volume 8, Issue 6, Pages e64260
Publisher
Public Library of Science (PLoS)
Online
2013-06-14
DOI
10.1371/journal.pone.0064260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Leveling the Playing Field: Bringing Development of Biomarkers and Molecular Diagnostics up to the Standards for Drug Development
- (2012) G. Poste et al. CLINICAL CANCER RESEARCH
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Second-Line Therapies in Hepatocellular Carcinoma: Emergence of Resistance to Sorafenib
- (2012) A. Villanueva et al. CLINICAL CANCER RESEARCH
- Bridging the Gap: Moving Predictive and Prognostic Assays from Research to Clinical Use
- (2012) P. M. Williams et al. CLINICAL CANCER RESEARCH
- Personalized medicine using DNA biomarkers: a review
- (2012) Andreas Ziegler et al. HUMAN GENETICS
- EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib
- (2012) Zakaria Ezzoukhry et al. INTERNATIONAL JOURNAL OF CANCER
- Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma
- (2012) Wolfgang Sieghart et al. JOURNAL OF HEPATOLOGY
- Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells
- (2012) Marie-José Blivet-Van Eggelpoël et al. JOURNAL OF HEPATOLOGY
- A Novel Classification of Lung Cancer into Molecular Subtypes
- (2012) Lisandra West et al. PLoS One
- Molecularly Targeted Therapy for Advanced Hepatocellular Carcinoma in 2012: Current Status and Future Perspectives
- (2012) Andrew X. Zhu SEMINARS IN ONCOLOGY
- Clinically Relevant Biomarkers to Select Patients for Targeted Inhibitor Therapy after Resection of Hepatocellular Carcinoma
- (2011) Sameer H. Patel et al. ANNALS OF SURGICAL ONCOLOGY
- Targeted Therapies for Hepatocellular Carcinoma
- (2011) Augusto Villanueva et al. GASTROENTEROLOGY
- Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma
- (2011) Soo Mi Kim et al. HEPATOLOGY
- A Melanoma Molecular Disease Model
- (2011) Smruti J. Vidwans et al. PLoS One
- Genetics of Hepatobiliary Carcinogenesis
- (2011) Jean-Charles Nault et al. SEMINARS IN LIVER DISEASE
- Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy
- (2010) Augusto Villanueva et al. Annual Review of Medicine
- Molecularly targeted therapy in hepatocellular carcinoma
- (2010) Hung Huynh BIOCHEMICAL PHARMACOLOGY
- Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers
- (2010) N. R. Smith et al. CLINICAL CANCER RESEARCH
- Overexpression of High-Mobility Group Box 2 Is Associated with Tumor Aggressiveness and Prognosis of Hepatocellular Carcinoma
- (2010) J.-H. Kwon et al. CLINICAL CANCER RESEARCH
- Hepatocellular carcinoma: a global view
- (2010) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
- (2010) Alejandro Forner et al. SEMINARS IN LIVER DISEASE
- Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
- (2009) Hung Huynh et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
- (2009) Pippa Newell et al. JOURNAL OF HEPATOLOGY
- The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma
- (2009) Ledu Zhou et al. MEDICAL ONCOLOGY
- Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines
- (2009) M. P. Morelli et al. MOLECULAR CANCER THERAPEUTICS
- Epidermal Growth Factor Receptor Expression and Gene Copy Number in Conventional Hepatocellular Carcinoma
- (2008) Anne F. Buckley et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma
- (2008) Z. Wang et al. CLINICAL CANCER RESEARCH
- Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival
- (2008) Jin-Bin Jia et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now